Table 2:
Patient Population | Medication | Dosing and Length of Treatment | ||
---|---|---|---|---|
Peri-Operative | Non-Penicillin Allergic | Ceftriaxone AND Ampicillin | Pre-op: ceftriaxone 2g IV AND ampicillin 2g IV Post-op: ceftriaxone 2g IV x 1 dose 24h after pre-op dose AND ampicillin 1g IV q6h (or per renal function) x 48 hours |
|
Penicillin Allergic | Vancomycin AND Ciprofloxacin | Pre-op vancomycin: 20mg/kg Pre-op ciprofloxacin: 400mg – 600mg IV Post-op: vancomycin 15mg/kg IV x 1 dose and ciprofloxacin 400mg IV x 1 dose 12 hours after pre-operative dose and then as per renal function for 48 hours total |
||
Fungal | High Risk Defined as > 1 of the following:
|
Fluconazole | 200 mg orally daily for 1 month | |
All others | No therapy | |||
Viral | High Risk | CMV IgG Donor + / Recipient − | Valganciclovir | 900 mg orally daily for 6 months |
Intermediate Risk | CMV IgG Donor + / Recipient + CMV IgG Donor − / Recipient + | Valganciclovir | 450 mg orally daily for 3 months | |
Low Risk | CMV IgG Donor − / Recipient − | Acyclovir | 800 mg orally twice daily for 1 month |
LT: liver transplant IV, intravenous; PRBC, packed red blood cells; IgG, immunoglobulin G